Zhitong Finance App News, Fosun Pharmaceutical (600196.SH) issued an announcement. Recently, the company's holding subsidiary, Fosun Wanbang (Jiangsu) Pharmaceutical Group Co., Ltd.'s application for drug registration of englizin metformin sustained-release tablets (III) was approved by the State Drug Administration. The approved indications are in combination with diet control and exercise, for adult patients with type 2 diabetes who are being treated with empagliflozin and metformin hydrochloride to improve blood sugar control in these patients.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.